RNAi therapeutics: a potential new class of pharmaceutical drugs

David Bumcrot(Alnylam Pharmaceuticals (United States)), Muthiah Manoharan(Alnylam Pharmaceuticals (United States)), Victor Koteliansky(Alnylam Pharmaceuticals (United States)), Dinah W.Y. Sah(Alnylam Pharmaceuticals (United States))
Nature Chemical Biology
November 16, 2006
10.1038/nchembio839
Cited by 1,082Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis